Our structure method may distinguish between brain tumors

Some of our Research Partners, Filip Szczepankiewicz et al., recently published The link between diffusion MRI and tumor heterogeneity: Mapping cell eccentricity and density by diffusional variance decomposition (DIVIDE) in NeuroImage.

In this proof-of-concept study, diffusion MRI using our software protocols for data acquisition and analysis was compared to biopsies of meningioma and glioma patients. The results of this publication excitingly provide convincing evidence that there exists a link between parameters from diffusion MRI and specific aspects of tissue architecture. Furthermore, the use of multidimensional diffusion MRI offers an improved interpretation of tumor tissue architecture, since the data it collects contains more information, already at acquisition. This brings hope that this non-invasive technique could aid in future diagnoses and treatment decisions.

If you are interested in the full article, please follow this link.

Congratulations on an elegant publication!

Random Walk Imaging AB is developing a novel proprietary approach to diffusion MRI. RWI is commercializing dVIEWR powered by MICE Toolkit™ as a novel software solution for clinical researchers and radiologists to better visualize and analyze diffusion MRI data. The company’s software solutions introduce a level of specificity to diffusion MRI that is unprecedented and that has the potential to non-invasively differentiate pathologies affected by changes in tissue microstructure. Based in Lund, part of the Swedish-Danish cross-border region of Medicon Valley, RWI has a broad intellectual property portfolio and unique translational expertise in advanced diffusion NMR and MRI methods.